Skip to main content

Table 4 Overview of Relevant Literature in the Treatment of Legg–Calve–Perthes Disease with Total Hip Arthroplasty

From: Monobloc implants in cementless total hip arthroplasty in patients with Legg-Calve-Perthes disease: a long-term follow-up

Study

Year

Patient (Hips)

Mean Age(y)

Mean FollowUp (yrs)

Implantation Type

Preoperative LLD(mm)

Postoperative LLD(mm)

Preoperative Function

Postoperative Function

Revision

Complication

Survival

Lee et al.

2017

68 (68)

48(16–73)

8.5(5.2–10)

Monobloc Cementless[Corail, DePuy]

NA

2.2(−2–14)

NA

HHS: 91 (73–100) UCLA activity: 5.5 (3–8)

None

Sciatic nerve palsy: 1 Ectopic ossification: 9

100%

Huang et al.

2016

33(33)

46.8 (24–72)

4.5 (2.2–11.3)

Various: Monobloc cementless: 22 Modular Femoral Component[SROM, DePuy]: 11

NA

NA

HHS: 37.6 (15–56)

HHS: 92.8(70–100) Diminished or no limping: 45% (15/33) dissatisfied: 9.1%(3/33)

None

Ectopic ossification: 2 Sciatic nerve palsy: 1 Intraoperative fracture: 4

NA

Lee et al.

2016

37(41)

43.8 ± 12.7 (18.9–66.3)

10.4 ± 3.3 (5.2–16.0)

Aluminae-alumina Cementless

20 ± 12

2 ± 9

HHS:66.7 ± 17.4

HHS: 96.8 ± 6.8 Lengthening: 17 ± 9 Diminished or no limping: 97% (36/37)

None

Intraoperative fracture: 14 Peroneal nerve palsy: 1 Deep vein thrombosis: 1

NA

Seufert et al.

2015

28(35)

51.6 (22–74)

8.2 (2–14)

Modular Femoral Component[SROM, DePuy]

18.6

7

HHS: 49.8 ± 9.2

HHS: 93.9 ± 8.5 Diminished or no limping: 94.3% (33/35)

Deep Infection: 1

Ectopic ossification: 2 Dislocation: 1

NA

Lim et al.

2014

23(23)

49.2 (25–69)

3.5 (2–7)

Monobloc Cementless: Bencox II 22,Accolade 1

15 (7–25)

3 (1–7)

HHS: 48.3 (42–67)

HHS: 92.4 (79–97)

Sciatic nerve palsy: 1

Sciatic nerve palsy: 1 Intraoperative fracture: 3

96%

Al-Khateeb et al.

2014

14(15)

32.8 (23–55)

10.1 (5–15)

Custom-made Cementless

NA

NA

HHS: 41(27–57) Trendelenburg sign(+): 11(78%) Walking aids: 8

HHS: 80(51–94) Trendelenburg sign(+): 3(21%) Walking aids: 1

Aseptic loosening: 3 Deep infection: 1

Ectopic ossification: 1 Dislocation: 1

Femoral stem: 100% Acetabular components: 79%

Baghdadi et al.

2013

95(99)

48 ± 15

8 ± 5

Cementless implants: 76 Hybrid implants:21

NA

NA

HHS: 56 (25–85)

HHS: 88 (50–100)

Aseptic loose stem component: 5 Liner wear: 3 Aseptic loose cup component: 1 Deep infection: 1

Intraoperative fracture: 8 (femoral), 1 (acetabular) Sciatic nerve palsy: 3 Thromboembolic: 1 Infection: 1 Dislocation: 1 Adductor tenotomy: 1

Cementless implants:90% (76%–96%) Hybrid implants:86% (57%–96%)

Traina et al.

2011

27(32)

37.8(19–65)

12.3(5–21)

Cement-less: 31 Cemented:1

NA

9(0–26)

HHS: 50.1(25–75)

HHS: 87.5 (73–96) Average Lengthening: 12 (6–27)

Failure for cemented component: 1

Sciatic nerve palsy: 2 Intraoperative fracture: 1 Hematoma: 1

96.9%(90.8% -100.0%)

Pietrzak et al.

2011

9(9)

56(41–69)

15(11–21)

Cement-less: 6 Cemented:3

NA

NA

HHS: 34 WOMAC: 77

HHS: 93 WOMAC: 6

None

NA

100%

Current study

2017

71(88)

49.94 ± 11.40(36–73)

10.09 ± 1.84(7.7–14)

Monobloc cementless: 88

24.3 ± 7.8(8–36)

2.4 ± 2.8(−2–10)

HHS: 46.42 ± 6.11, Sym: 11.37 ± 2.40, Pain:19.39 ± 5.90, DL: 34.80 ± 3.78, SARA: 8.07 ± 1.77, QOF: 6.62 ± 1.21, PCS: 15.80 ± 2.69, MCS: 16.63 ± 2.80

HHS: 89.70 ± 5.46, Sym: 17.19 ± 1.45, Pain:37.32 ± 2.05, DL: 65.77 ± 1.17, SARA: 14.55 ± 1.96, QOF: 13.42 ± 1.31, PCS: 23.11 ± 2.78, MCS: 24.55 ± 3.13

Fracture: 1

Intraoperativel fracture: 2 Sciatic nerve palsy:2 Heterotopic ossification: 2 Dislocation: 1 Thigh pain: 1

98.3%(94.9%–99.9%)

  1. LLD Limb length discrepancy, HHS Harris Hip Score, UCLA University of California activity, Los Angeles activity scales, WOMAC The Western Ontario and McMaster Universities Osteoarthritis Index, Sym Symptoms, DL Daily living, SARA Sports and recreational activities, QOF Quality of life, PCS physical component summary, MCS mental component summary, NA not applicable